The CD81 partner EWI-2wint inhibits hepatitis C virus entry.

Two to three percent of the world's population is chronically infected with hepatitis C virus (HCV) and thus at risk of developing liver cancer. Although precise mechanisms regulating HCV entry into hepatic cells are still unknown, several cell surface proteins have been identified as entry fac...

Full description

Bibliographic Details
Main Authors: Vera Rocha-Perugini, Claire Montpellier, David Delgrange, Czeslaw Wychowski, François Helle, André Pillez, Hervé Drobecq, François Le Naour, Stéphanie Charrin, Shoshana Levy, Eric Rubinstein, Jean Dubuisson, Laurence Cocquerel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-04-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2270906?pdf=render